Bill
Therapeutic Goods Amendment (2020 Measures No. 2) Bill 2020
passed, as at 2021-02-19. Health portfolio.
- Sponsor
- Not recorded
- Portfolio
- Health
Recorded stages
- introduced — 2020-12-09
- second reading — 2020-12-09
- second reading — 2021-02-02
- second reading — 2021-02-03
- second reading — 2021-02-03
- third reading — 2021-02-03
- introduced — 2021-02-03
- second reading — 2021-02-03
- second reading — 2021-02-18
- second reading — 2021-02-18
- third reading — 2021-02-18
- passed — 2021-02-18
- royal assent — 2021-02-19
Divisions
Plain-language summary
Written by a model from the Bills Digest; not the record, as at 2020-12-09.
The bill would let pharmacists substitute one prescription medicine for another when the minister declares a serious shortage.
The minister could make a legislative instrument declaring a serious scarcity of a medicine and naming a substitute that pharmacists may dispense instead.
The scheme would apply only to Schedule 4 prescription medicines, not to Schedule 8 controlled drugs such as cocaine or morphine.
- Inserts a new object into the Act to allow pharmacist substitution of medicines during a serious scarcity.
- Creates a new division that lets the minister declare a serious scarcity and specify a substitutable medicine.
- Authorises pharmacists to dispense the substitute even if state or territory law would otherwise prohibit it.
- Allows the minister to delegate the power to make a serious scarcity declaration to the Secretary of Health or a senior executive.
- Adds provisions for regulations to establish a database of unique device identifiers for medical devices.
Pharmacists, patients, the Minister for Health, the Department of Health, and manufacturers of prescription medicines and medical devices.
Sources
em
digest
billhome
frl act